2025-03-10 20:58:26
Latest Post
Syngene acquires its First Manufacturing Facility in the US 
Thermax Partners with Brazil-Based OCQ for High-Performance Chemicals
BEL receives orders worth Rs.843 Crore
RVNL signed MoU with M/s Abhinava Strategic Partners Pvt Ltd
Gensol Engineering promoter demonstrates unwavering commitment with INR 29 Cr. Equity Infusion
Stock Report
TCM Ltd Q3FY23 consolidated loss at Rs. 1.28 crore
Posted On : 2023-02-08 13:53:31( TIMEZONE : IST )
TCM LTD. has reported Consolidated financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 0.7881 crores during the period ended December 31, 2022 as compared to Rs. 1.0453 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. -1.2851 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. -0.6184 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. -1.72 for the period ended December 31, 2022 as compared to Rs. -0.83 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹0.7881 crs | ₹1.0453 crs |  -24.61% |
| Net Profit | ₹-1.2851 crs | ₹-0.6184 crs |  107.81% |
| EPS | ₹-1.72 | ₹-0.83 | 107.23% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.0.7881 crores during the period ended December 31, 2022 as compared to Rs.0.1103 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.-1.2851 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.-0.8926 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.-1.72 for the period ended December 31, 2022 as compared to Rs.-2.63 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹0.7881 crs | ₹0.1103 crs |  614.51% |
| Net Profit | ₹-1.2851 crs | ₹-0.8926 crs | 43.97% |
| EPS | ₹-1.72 | ₹-2.63 |  34.60% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.2.4567 crores during the 9 Months period ended December 31, 2022 as compared to Rs.2.5650 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.-2.9916 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.-0.8954 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.-5.25 for the 9 Months period ended December 31, 2022 as compared to Rs.-2.63 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹2.4567 crs | ₹2.5650 crs | -4.22% |
| Net Profit | ₹-2.9916 crs | ₹-0.8954 crs | 234.11% |
| EPS | ₹-5.25 | ₹-2.63 | 99.62% |
Shares of TCM LTD. was last trading in BSE at Rs. 37.05 as compared to the previous close of Rs. 36.40. The total number of shares traded during the day was 2679 in over 21 trades.
The stock hit an intraday high of Rs. 38.85 and intraday low of 37.05. The net turnover during the day was Rs. 101754.00.
